Dear Reader

• A Message from the President

Scientific & Clinical

•  REVLIMID® Approved for Myeloma
•  Summary of New International Uniform Response Criteria for Myeloma
• Progress Report from the IMF's Senior Research Grant Recipient, Manuel L. Penichet, MD, PhD
•  VEL-CTD in Previously Untreated Multiple Myeloma

Education & Awareness

• Patient & Family Seminar: Portland, Oregon
• Patient & Family Seminar: Philadelphia, Pennsylvania
•  2006 Myeloma Awareness Week!
•  IMF's Fiscal Year 2007 Funding Priorities and Call to Action

Special Event

•  Last Chance to Join Us for the IMF's 16th Anniversary Gala!

International

• Europeans Attend IMF Support Group Leaders Retreat
•  Update from the Israeli Association of Myeloma Patients (AMEN)
• Ontario Covers Myeloma Drug
• IMF Latin America Hosts Five Patient & Family Seminars

Supportive Care

•  Osteonecrosis of the Jaw and Oral Care

Supportive Care

• Mayo Clinic Consensus Statement for the Use of Bisphosphonates in Myeloma
•  IMF Hotline Coordinators Answer Your Questions: "Do you have any tips for drug access and reimbursement, especially for Revlimid®?"

Support Groups

• Spotlight on Portland, Oregon
• The Philadelphia Story!
• The IMF Welcomes New Myeloma Support Groups

Patient & Caregiver Experience:

• Shifting Focus: My "New" Life with Multiple Myeloma
• PHow I Celebrated My 8th Birthday

Member Events

• 13th Birthday Celebration Honors Myeloma Survivor
• Terry DuBois Celebrates His 65th Birthday with a Bash!
•  5th Annual Multiple Musicians Against Multiple Myeloma
•  5th Annual WAMP Swim-a-Thon
• LaSalle Bank Chicago Distance Classic
•  Kids Fight Back! - A New Program Just for Young People

Meet the IMF

•  A Conversation with Candace McDonald and Suzanne Battaglia

Board Member Profile

• Gregory R. Mundy, MD

Scientific Advisor Profile

• Jesus San Miguel, MD, PhD
   

News & Notes
 

Letters to the IMF

Click here to download Myeloma Today